Bentracimab (PB2452) Infusion

DRUG2 trials

Sponsors

SFJ Pharmaceuticals, Inc.

Conditions

HealthyHemorrhageInvasive ProcedureUrgent Surgery

Phase 2

Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old

CompletedNCT04122170

SFJ Pharmaceuticals, Inc.Healthy

Start: 2019-09-24End: 2021-09-01Updated: 2024-04-08

Phase 3

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

CompletedNCT04286438

SFJ Pharmaceuticals, Inc.Hemorrhage, Invasive Procedure, Urgent Surgery

Start: 2020-07-15End: 2024-09-09Updated: 2024-10-21

Related Papers

Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery

NEJM Evidence2021-12-2249 citations